Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125332438> ?p ?o ?g. }
- W2125332438 abstract "Background The discovery of somatostatin (SST) and the synthesis of a variety of analogues constituted a major therapeutic advance in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours (GEP-NETs). They currently provide the most efficient treatment to achieve symptomatic relief and have recently been demonstrated to inhibit tumour growth. Aim To review 35 years of experience regarding the clinical application and efficacy of SST analogues. Methods The PubMed database (1972–2009) was searched using somatostatin as a search term with combinations of terms including ‘treatment’; ‘neuroendocrine’; ‘carcinoid’; ‘tumor’; ‘octreotide’; ‘lanreotide’ and ‘pasireotide’. Results In a review of 15 studies including 481 patients, the slow-release formulations Sandostatin LAR and Somatuline SR/Autogel achieved symptomatic relief in 74.2% (61.9–92.8%) and 67.5% (40.0–100%), biochemical response in 51.4% (31.5–100%) and 39.0% (17.9–58%), and tumour response in 69.8% (47.0–87.5%) and 64.4% (48.0–87.0%) respectively. Novel SST analogues like SOM230 (pasireotide) that exhibit pan SST receptor activity and analogues with high affinity to specific somatostatin receptor (sstr) subtypes may further advance the field, but efficacy studies are lacking. Conclusion As more precise understanding of NET cell biology evolves and molecular biological tools advance, more accurate identification of individual tumours sstr profile will probably facilitate a more precise delineation of SST analogue treatment. Aliment Pharmacol Ther 31, 169–188" @default.
- W2125332438 created "2016-06-24" @default.
- W2125332438 creator A5009119423 @default.
- W2125332438 creator A5055143638 @default.
- W2125332438 creator A5067194567 @default.
- W2125332438 creator A5086888726 @default.
- W2125332438 date "2009-10-01" @default.
- W2125332438 modified "2023-10-18" @default.
- W2125332438 title "Review article: somatostatin analogs in the treatment of gastro-entero-pancreatic neuroendocrine (carcinoid) tumors" @default.
- W2125332438 cites W111780214 @default.
- W2125332438 cites W131003897 @default.
- W2125332438 cites W1537185980 @default.
- W2125332438 cites W1559045450 @default.
- W2125332438 cites W1583777607 @default.
- W2125332438 cites W1898402948 @default.
- W2125332438 cites W1969594608 @default.
- W2125332438 cites W1970015981 @default.
- W2125332438 cites W1976198807 @default.
- W2125332438 cites W1976471069 @default.
- W2125332438 cites W1977347411 @default.
- W2125332438 cites W1977395984 @default.
- W2125332438 cites W1978833437 @default.
- W2125332438 cites W1979332785 @default.
- W2125332438 cites W1981326638 @default.
- W2125332438 cites W1981382809 @default.
- W2125332438 cites W1981547344 @default.
- W2125332438 cites W1982298992 @default.
- W2125332438 cites W1983868619 @default.
- W2125332438 cites W1984292444 @default.
- W2125332438 cites W1988395319 @default.
- W2125332438 cites W1991487107 @default.
- W2125332438 cites W1993415924 @default.
- W2125332438 cites W1993421446 @default.
- W2125332438 cites W1994663521 @default.
- W2125332438 cites W1995380349 @default.
- W2125332438 cites W1996231078 @default.
- W2125332438 cites W1998795762 @default.
- W2125332438 cites W2004291258 @default.
- W2125332438 cites W2005042277 @default.
- W2125332438 cites W2005112918 @default.
- W2125332438 cites W2006222114 @default.
- W2125332438 cites W2006611896 @default.
- W2125332438 cites W2008788040 @default.
- W2125332438 cites W2011444335 @default.
- W2125332438 cites W2011678905 @default.
- W2125332438 cites W2011732158 @default.
- W2125332438 cites W2012020661 @default.
- W2125332438 cites W2012451298 @default.
- W2125332438 cites W2013839190 @default.
- W2125332438 cites W2014096936 @default.
- W2125332438 cites W2017082986 @default.
- W2125332438 cites W2017600233 @default.
- W2125332438 cites W2018042027 @default.
- W2125332438 cites W2020146565 @default.
- W2125332438 cites W2022203930 @default.
- W2125332438 cites W2022563719 @default.
- W2125332438 cites W2024818260 @default.
- W2125332438 cites W2027867142 @default.
- W2125332438 cites W2029833280 @default.
- W2125332438 cites W2030100050 @default.
- W2125332438 cites W2033105972 @default.
- W2125332438 cites W2035733823 @default.
- W2125332438 cites W2036388279 @default.
- W2125332438 cites W2037232466 @default.
- W2125332438 cites W2038309945 @default.
- W2125332438 cites W2039460274 @default.
- W2125332438 cites W2040127137 @default.
- W2125332438 cites W2041357642 @default.
- W2125332438 cites W2042529958 @default.
- W2125332438 cites W2047218968 @default.
- W2125332438 cites W2049780571 @default.
- W2125332438 cites W2053295915 @default.
- W2125332438 cites W2053999826 @default.
- W2125332438 cites W2054318763 @default.
- W2125332438 cites W2057289630 @default.
- W2125332438 cites W2060013854 @default.
- W2125332438 cites W2062939394 @default.
- W2125332438 cites W2063850840 @default.
- W2125332438 cites W2066524003 @default.
- W2125332438 cites W2067084033 @default.
- W2125332438 cites W2070517189 @default.
- W2125332438 cites W2071310612 @default.
- W2125332438 cites W2073754493 @default.
- W2125332438 cites W2077123274 @default.
- W2125332438 cites W2077315581 @default.
- W2125332438 cites W2080129478 @default.
- W2125332438 cites W2080232093 @default.
- W2125332438 cites W2081019043 @default.
- W2125332438 cites W2081690922 @default.
- W2125332438 cites W2082639053 @default.
- W2125332438 cites W2084147905 @default.
- W2125332438 cites W2085340550 @default.
- W2125332438 cites W2087603615 @default.
- W2125332438 cites W2092374171 @default.
- W2125332438 cites W2094229678 @default.
- W2125332438 cites W2094900176 @default.
- W2125332438 cites W2095312317 @default.
- W2125332438 cites W2100283328 @default.
- W2125332438 cites W2104955808 @default.
- W2125332438 cites W2105166510 @default.